Cutera (NASDAQ:CUTR) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a note issued to investors on Monday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Stock Performance

NASDAQ CUTR opened at $0.04 on Monday. The stock has a market cap of $787,254.00, a P/E ratio of -0.01 and a beta of 1.36. Cutera has a fifty-two week low of $0.09 and a fifty-two week high of $3.00. The stock has a 50 day simple moving average of $0.08 and a two-hundred day simple moving average of $0.32.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Cutera stock. Sculptor Capital LP purchased a new position in Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned approximately 0.82% of Cutera at the end of the most recent reporting period. 90.70% of the stock is owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.